Catalysts for $IKT
10 tracked
Aug 13, 2026
earnings
Inhibikase Therapeutics, Inc. earnings
Inhibikase Therapeutics, Inc.
→
May 13, 2026
earnings
Inhibikase Therapeutics, Inc. earnings
Inhibikase Therapeutics, Inc.
→
May 12, 2026
earnings
Inhibikase Therapeutics, Inc. earnings
Inhibikase Therapeutics, Inc.
→
Apr 6, 2026
approval
IMATINIB MESYLATE — FDA approval
Inhibikase Therapeutics, Inc.
→
Apr 6, 2026
approval
IMATINIB MESYLATE — FDA approval
Inhibikase Therapeutics, Inc.
→
Jan 31, 2023
approval
IMATINIB MESYLATE — FDA approval
Inhibikase Therapeutics, Inc.
→
Jan 31, 2023
approval
IMATINIB MESYLATE — FDA approval
Inhibikase Therapeutics, Inc.
→
Jan 31, 2023
approval
IMATINIB MESYLATE — FDA approval
Inhibikase Therapeutics, Inc.
→
Jan 31, 2023
approval
IMATINIB MESYLATE — FDA approval
Inhibikase Therapeutics, Inc.
→
Jul 23, 2020
approval
IMATINIB MESYLATE — FDA approval
Inhibikase Therapeutics, Inc.
→